Empire Genomics - Enabling Personalized Medicine

New Products & Services

Empire Genomics (EG) is a molecular diagnostics company that develops and offers a comprehensive menu of assay services for use in diagnosing and guiding precise therapeutic treatments for patients. The EG services are designed to specifically meet the needs of pathologists, oncologists and researchers. Our mission is to address the problem the medical community faces with the rapid pace of molecular technology innovations, and the need for the delivery of clinically relevant, cost effective patient decision support tools. Ultimately, through our continued growth customers will be able to realize: faster and more effective drug development, lower healthcare costs, and better clinical outcomes for patients. Empire is uniquely positioned to bring this innovative service to the medical community through its highly qualified team, state of the art facilities and key strategic partnerships with leaders in the global research community. We are a resource to make personalized medicine a reality for you.

Recent News

Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer

Empire Genomics announced today it has acquired an exclusive license for a patent pending novel genomic biomarker from Cornell University for use in d...

Full Article


Buffalo has a presence at major Chicago event

A contingent including representatives from 12 area life-sciences companies and the major institutions on the Buffalo Niagara Medical Campus is in Chi...

Full Article


Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma

Gene organization in nonmalignant B cells from t(4;14) and t(11;14) multiple myeloma (MM) patients differs from that of healthy donors. Among recurren...

Full Article


view all news articles